AI is making an impact in the early stages of drug discovery. It can scan huge chemical and biological datasets, predict how compounds may behave, and suggest new molecular designs. 

AI won’t replace pharma scientists but it will redefine their work! Here's why

In anticipation of the tariffs, several major pharmaceutical companies, including Novartis, Sanofi, Roche, and US-based Eli Lilly and Johnson & Johnson, have announced large-scale investments in US manufacturing. 

Pharmaceutical industry braces for impact as Trump threatens 200% tariffs

Business & Economy: Trump asserts that this move could cut drug prices by as much as 30 per cent to 80 per cent, offering relief to millions of American consumers.

Donald Trump plans major move to cut drug prices by up to 80%

Indian competitors are gaining from the pharmaceutical industry's efforts to reduce its dependency on Chinese suppliers of medications for clinical trials and early-stage manufacturing. Due to the low cost and quick turnaround times provided by contract drugmakers, China has been the go-to destination for a variety of pharmaceutical research and manufacturing services for almost 20 years.

Indian drug manufacturers benefit from 'big pharma' amid tensions with China

The public investment fund, or pif, is making groundbreaking strides toward diversifying the nation's economy, in a bid to reduce reliance on oil sales. The PIF has announced the launch of Lifera, which is aimed at revolutionizing the pharmaceutical industry. Lifera, created by the PIF, aims to attract local and international pharmaceutical and biotech companies to invest in drug manufacturing

Saudi Arabia's sovereign wealth fund enters pharmaceutical

The cross-country intellectual property rights (IPRs) wars are back and this time it’s being fought in the East. From last week’s RCEP conversations in Singapore, it seems like Japan and South Korea are pushing other Asian countries like India and China to accede to stricter IPR norms.

Cross-country IPR wars are back

The first stage would take place at four Java hospitals and clinics, where children had received fake vaccines

Indonesia re-vaccinates children amid fake drug scandal

Global pressure on health spending is forcing the $1 trillion-a-year pharmaceutical industry to look for new ways to price its products

Future of drug pricing: Paying for benefits not per pill

pharmaceutical-industry

Pharmaceutical Industry, News on Pharmaceutical Industry, stories on Pharmaceutical Industry, articles on Pharmaceutical Industry, Pharmaceutical Industry stories at Wion, Pharmaceutical Industry news, Pharmaceutical Industry latest news